Diagnostic value of platelet to high-density lipoprotein cholesterol ratio in abdominal aortic aneurysms

Xiao Du1, Jin Xu2, Shilan Zhang3

  • 1Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

PubMed

Insights

The platelet-to-HDL cholesterol ratio (PHR) is a novel biomarker for abdominal aortic aneurysm (AAA). Higher PHR levels indicate AAA presence and thrombosis, suggesting its utility as a rapid diagnostic indicator.

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Discovery
  • Medical Diagnostics

Background:

  • Abdominal aortic aneurysm (AAA) presents a significant mortality risk.
  • Current AAA diagnosis relies heavily on imaging, necessitating simpler screening biomarkers.
  • The platelet-to-high-density lipoprotein cholesterol ratio (PHR) reflects systemic inflammation and hypercoagulable states.

Purpose of the Study:

  • To investigate the clinical significance of the PHR as a biomarker for AAA.
  • To evaluate PHR's diagnostic and predictive value in patients with AAA, including those with thrombosis.

Main Methods:

  • A cohort study involving 156 AAA patients and 113 healthy controls.
  • Serum PHR levels were calculated using [platelet count (1,000 cells/µl) / HDL-C (mmol/L)].
  • Receiver operating characteristic (ROC) analysis and logistic regression were employed to assess predictive value and identify independent predictors.

Main Results:

  • PHR levels were significantly elevated in AAA patients compared to controls (192.35 vs. 127.00, P < 0.001).
  • PHR was even higher in AAA patients with thrombosis (220.61 vs. 161.80, P < 0.001).
  • PHR demonstrated good predictive value for AAA diagnosis (AUC = 0.805) and for AAA with thrombosis (AUC = 0.814), and was an independent predictor for both conditions.

Conclusions:

  • The PHR exhibits significant diagnostic value for abdominal aortic aneurysm.
  • PHR can function as a rapid and effective screening indicator for clinical AAA diagnosis.
  • Elevated PHR levels are associated with the presence of AAA and concomitant thrombosis.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
377
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
339
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
295
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
450